Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL108482 | 0.76 | CA1 (0.41) | CA1CA2CA7CA13 | |
| SCHEMBL15267708 | 0.76 | CA1 (0.32) | CA1CA2CA7CA13 | |
| SCHEMBL14219800 | 0.74 | EPHX1 (0.34) | CA1CA2CA7CA13 | |
| Hydrogen Sulfide SCHEMBL29555265 | 0.74 | CA1 (0.39) | CA1CA2CA7CA13 | |
| Ammonia Solution, Strong SCHEMBL31709538 | 0.74 | CA1 (0.39) | CA1CA2CA7CA13 | |
| SCHEMBL7620589 | 0.74 | CA1 (0.39) | CA1CA2CA7CA13 | |
| Lithium SCHEMBL29624274 | 0.74 | CA1 (0.39) | CA1CA2CA7CA13 | |
| Potassium SCHEMBL29714737 | 0.74 | CA1 (0.39) | CA1CA2CA7CA13 | |
| SCHEMBL438535 | 0.74 | CA1 (0.39) | CA1CA2CA7CA13 | |
| Iodide SCHEMBL29482281 | 0.74 | CA1 (0.39) | CA1CA2CA7CA13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11754926-B2 | Method of forming resist pattern, resist composition and method of producing the same | TOKYO OHKA KOGYO CO., LTD. (JP) | 2023-09-12 | — | — | US | disclosed |
| US-20200150541-A1 | METHOD OF FORMING RESIST PATTERN, RESIST COMPOSITION AND METHOD OF PRODUCING THE SAME | TOKYO OHKA KOGYO CO., LTD. (JP) | 2020-05-14 | — | — | US | disclosed |